CPAP Therapy for Infants with Respiratory Distress in Non-Tertiary Care
Investigating the effectiveness of CPAP therapy vs. headbox oxygen treatment in reducing NICU transfers in infants with respiratory distress. Results show significant benefits and reduction in treatment failure.
CPAP Therapy for Infants with Respiratory Distress in Non-Tertiary Care
E N D
Presentation Transcript
CATS Justine Iris Yap, MD Lia May Banting-Tapangco, MD 25 September 2010
Clinical Scenario: • OA was born PT 32wks by PA, 1300g SGA, LBW, del via LSCS, LBB AS 5,6 • Upon birth patient was limp, cyanotic HR<100 PPV was done • After 30s, HR140, RR70, w/ some movement, acrocyanotic, w/ note of alar flaring & grunting • Patient was placed on 100% O2 hood but there was persistence of tachypnea, alar flaring & grunting • Pxt was intubated ET2.5L7 and hooked to MV
Clinical Question Among infants with respiratory distress syndrome treated in non-tertiary care, will the use of CPAP therapy reduce the number of transfer to a NICU?
P: Infants <24 hours of age with clinical signs of respiratory distress I: CPAP therapy vs headbox oxygen treatment O: uptransfer or treatment failure M: Randomized Controlled Trial
Study Characteristics • Patients included • All infants < 24 hours of age with clinical signs of respiratory distress who required >30% oxygen in a headbox to maintain O2 saturations of >/= 94% for > 30 minutes
Study Characteristics • Interventions Compared • CPAP therapy versus headbox oxygen therapy
Study Characteristics • Outcomes Monitored • Uptranser or Treatment Failure • Parameters of treatment failure: FiO2 (>/= 60% for the headbox group or >/= for the CPAP group) CO2 level and pH (CO2 of >60 mmHg or pH <7.25 in 2 successive gas samples >/= 1 hour apart • Nursery Length of stay • Length of oxygen treatment
Validity Criteria • Were patients randomized • YES. Random allocation was computer-generated • Was randomization concealed? • No • Were the patients analyzed in the groups to which they were randomized • YES
Validity Criteria • Were patients in the treatment and control groups similar at baseline? • YES • Were patients aware of group allocation? • YES • Were the clinicians aware of group allocation? • YES
Validity Criteria • Were outcome assessors aware of group allocation? • YES • Was follow-up complete? • YES
Results • Risk in Control • Uptransfer in control/N patients in control 54/149 = 0.36 • Treatment failure in control/N patients in control 47/149 = 0.31 • Risk in Treatment • Uptransfer in treatment/N patients in treatment 34/151 = 0.22 • Treatment failure in treatment/N patients in treatment 30/151 = 0.20
Results • Absolute Risk Reduction • Risk in Control – Risk in Treatment 0.36 – 0.22 = 0.14 ; Among 100 patients, there will be 17 less cases of uptransfer with CPAP therapy. 0.31 – 0.20 = 0.11 ; Among 100 patients, there will be 11 less cases of treatment failure with CPAP therapy • Relative risk • Risk in Treatment/Risk in Control 0.22/0.36 = 0.61 ; The risk of uptransfer is 61% less with CPAP therapy 0.20/0.31 = 0.65; The risk of treatment failure is 65% less with CPAP therapy
Results • Relative risk reduction • 1 – relative risk 1 – 0.61 = 0.39; The risk of uptransfer is decreased by 39% with CPAP therapy 1 – 0.65 = 0.35; The risk of treatment failure is decreased by 35% with CPAP therapy • Number needed to treat • 1 / absolute risk reduction = 1/ 0.14 = 3.86; We need to treat 4 patients in order to prevent uptransfer with CPAP therapy 1/ 0.11 = 9; We need to treat 9 patients in order to prevent treatment failure with CPAP therapy
Applicability • Are the study patients similar to the patients in my practice? YES • Were all clinically relevant outcomes reported? YES • Are the likely treatment benefits worth the harm and costs? YES
Authors’ Conclusion CPAP therapy provides significant benefits to infants with respiratory distress in large non-tertiary center with appropriate staff training
Reviewers’ Conclusion CPAP therapy among infants with respiratory distress reduced the number of transfer to NICU and treatment failure